Anguita M, Arizón J M, Vallés F, Torres F, Giménez D, Casares J, López-Granados A, Mesa D, Latre J M, Concha M
Heart Transplantation Unit, Reina Sofía Hospital, University of Córdoba, Spain.
J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):974-82.
In an attempt to study the influence of heart transplantation on the natural history of patients with severe congestive heart failure, we have reviewed our experience with 240 consecutive patients who were New York Heart Association class IV or III/IV, who had left ventricular ejection fraction less than 35%, who were younger than 65 years of age, and who were assessed for heart transplantation in our hospital since May 1986. Mean age was 47 +/- 12 years. Left ventricular ejection fraction was 20% +/- 6%. Eighty-seven percent were male. New York Heart Association class was IV in 88% and III/IV in 12%. The cause was ischemic heart disease in 35% of patients, valvular heart disease in 13% of patients, and primary dilated cardiomyopathy in 52% of patients. At initial assessment, heart transplantation was considered to be not indicated in 30% of patients, indicated in 51% of patients, and contraindicated in 19% of patients. During a follow-up of 13 +/- 13 months (2 to 64 months), 110 patients underwent transplantation (46%). Posttransplantation actuarial probability of survival was 70% at 3 years. Three-year probability of survival free from transplantation was significantly lower for patients older than 55 years of age (p < 0.05), for those with left ventricular ejection fraction less than 20% (p < 0.05), ischemic causes (p < 0.05), New York Heart Association class IV (p < 0.001), and indication/contraindication for transplantation (p < 0.001); no difference was noted for gender.(ABSTRACT TRUNCATED AT 250 WORDS)
为了研究心脏移植对重度充血性心力衰竭患者自然病程的影响,我们回顾了自1986年5月以来在我院接受心脏移植评估的240例连续患者的经验。这些患者均为纽约心脏协会心功能IV级或III/IV级,左心室射血分数低于35%,年龄小于65岁。平均年龄为47±12岁。左心室射血分数为20%±6%。87%为男性。88%的患者纽约心脏协会心功能为IV级,12%为III/IV级。35%的患者病因是缺血性心脏病,13%是瓣膜性心脏病,52%是原发性扩张型心肌病。在初始评估时,30%的患者被认为不适合进行心脏移植,51%的患者适合,19%的患者为禁忌。在13±13个月(2至64个月)的随访期间,110例患者接受了移植(46%)。移植后3年的精算生存率为70%。年龄大于55岁的患者(p<0.05)、左心室射血分数低于20%的患者(p<0.05)、缺血性病因的患者(p<0.05)、纽约心脏协会心功能IV级的患者(p<0.001)以及移植适应证/禁忌证的患者(p<0.001),其3年无移植生存率显著较低;性别方面未发现差异。(摘要截断于250字)